product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
IκB-ζ Antibody
catalog :
9244
clonality :
polyclonal
host :
domestic rabbit
conjugate :
nonconjugated
reactivity :
human
application :
western blot, immunoprecipitation
citations: 4
Published Application/Species/Sample/DilutionReference
  • western blot; human; fig 1a
Muller A, Dickmanns A, Resch C, Schakel K, Hailfinger S, Dobbelstein M, et al. The CDK4/6-EZH2 pathway is a potential therapeutic target for psoriasis. J Clin Invest. 2020;: pubmed publisher
  • western blot; human; loading ...; fig 5c
Domae E, Hirai Y, Ikeo T, Goda S, Shimizu Y. Cytokine-mediated activation of human ex vivo-expanded V?9V?2 T cells. Oncotarget. 2017;8:45928-45942 pubmed publisher
  • western blot; human; loading ...; fig 2a
Wang C, Guo S, Wang J, Yan X, Farrelly M, Zhang Y, et al. Reactivation of ERK and Akt confers resistance of mutant BRAF colon cancer cells to the HSP90 inhibitor AUY922. Oncotarget. 2016;7:49597-49610 pubmed publisher
  • western blot; human; loading ...; fig 3d
Zimmermann M, Arruda Silva F, Bianchetto Aguilera F, Finotti G, Calzetti F, Scapini P, et al. IFNα enhances the production of IL-6 by human neutrophils activated via TLR8. Sci Rep. 2016;6:19674 pubmed publisher
product information
SKU :
9244S
Product-Name :
IκB-ζ Antibody
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H
Applications :
Immunoprecipitation
Product-Category :
Immunology and Inflammation
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Polyclonal Antibody
MW :
78
Host :
Rabbit
Target :
IkB-zeta
Primary-Protein :
IkB-zeta
Alt-Names :
FLJ30225,FLJ34463,I-kappa-B-zeta,IKBZ,IL-1 inducible nuclear ankyrin-repeat protein,INAP,IkB-zeta,Ikappa B-zeta variant 3,IkappaB-zeta,IkappaBzeta,MAIL,Molecule possessing ankyrin repeats induced by lipopolysaccharide,NF-kappa-B inhibitor zeta,NFKBIZ,nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
https://www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.